<?xml version="1.0" encoding="UTF-8"?>
<p>
 <italic>Mycoplasma pneumoniae</italic> is a common bacterial cause of pneumonia and bronchitis in humans [
 <xref rid="pone.0209938.ref001" ref-type="bibr">1</xref>â€“
 <xref rid="pone.0209938.ref003" ref-type="bibr">3</xref>]. Pneumonia caused by this organism accounts for a significant part of community-acquired pneumonia cases worldwide and is particularly common in children and young adults [
 <xref rid="pone.0209938.ref001" ref-type="bibr">1</xref>,
 <xref rid="pone.0209938.ref003" ref-type="bibr">3</xref>]. In most cases, symptoms of 
 <italic>M</italic>. 
 <italic>pneumoniae</italic> pneumonia are relatively mild. However, serious cases with various complications that require hospitalization are not uncommon [
 <xref rid="pone.0209938.ref004" ref-type="bibr">4</xref>]. Macrolide resistance (MR) is a recent global concern for clinical treatment of 
 <italic>M</italic>. 
 <italic>pneumoniae</italic> pneumonia [
 <xref rid="pone.0209938.ref005" ref-type="bibr">5</xref>,
 <xref rid="pone.0209938.ref006" ref-type="bibr">6</xref>]. Macrolide-resistant 
 <italic>M</italic>. 
 <italic>pneumoniae</italic> (MRMP) is highly prevalent in Asian countries, including China, Korea, and Japan. Moreover, it is gradually increasing in other areas of the world as well [
 <xref rid="pone.0209938.ref002" ref-type="bibr">2</xref>,
 <xref rid="pone.0209938.ref007" ref-type="bibr">7</xref>,
 <xref rid="pone.0209938.ref008" ref-type="bibr">8</xref>].
</p>
